Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 301 - 350 of 4862 results
- Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
- Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function.
- betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction.
- Angiotensin receptor blockade decreases markers of vascular inflammation.
- Nitric-oxide mediated effects of transdermal capsaicin patches on the ischemic threshold in patients with stable coronary disease.
- Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
- In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult.
- Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats.
- Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
- The erythropoietin-receptor pathway modulates survival of cancer cells.
- Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.
- Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
- Nasal administration of albuterol: an alternative route of delivery.
- Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
- Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
- Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin.
- Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration.
- Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists.
- ASHP Therapeutic Position Statement on the Use of Low-Molecular-Weight Heparins for Adult Outpatient Treatment of Acute Deep-Vein Thrombosis.
- Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stenting.
- Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol.
- The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
- p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
- Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.
- Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference.
- Hydrocortisone reduces restenosis after stenting of small coronary arteries.
- Double transgenic mice with type 1 diabetes mellitus develop somatic, metabolic and vascular disorders.
- Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
- Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo.
- Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.
- Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide.
- Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.
- Cardioprotective effects of vasopeptidase inhibition vs. angiotensin type 1-receptor blockade in spontaneously hypertensive rats on a high salt diet.
- Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts.
- Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome.
- Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
- Stroke risk and tamoxifen therapy for breast cancer.
- Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.
- Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis.
- Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury.
- Glycoprotein IIb/IIIa receptor antagonists and risk of bleeding: a single-center experience in 1020 patients.
- Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
- Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat.
- Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure.
- 1,2,3,4-Tetrahydroquinoline-containing alphaVbeta3 integrin antagonists with enhanced oral bioavailability.
- CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
- Superoxide dismutase mimetic m40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts.
- TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy.
- Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis.
- Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >